ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Setsuro Tech, a biotechnology start-up using genome-editing techniques to develop and supply cell and animal models, announced a non-exclusive license agreement granting Setsuro Tech access to ERS Genomics’ CRISPR/Cas9 patent portfolio for Japan.
PLEASANT PRAIRE, Wis., June 24, 2020 /PRNewswire/ -- Quest Products, LLLC. (Quest) today announced its acquisition of Summit Pharmaceuticals / Alliance Labs. Quest is a portfolio company of Promus Equity Partners (Promus).
Germany based Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biopharmaceuticals, hasreported that it will further enhance and develop the existing collaboration in Japan with Summit Pharmaceuticals International Corporation (SPI), a wholly owned subsidiary of Sumitomo Corporation.
Contract manufacturer Rentschler Biopharma has revealed plans to further enhance and develop the existing collaboration in Japan with Summit Pharmaceuticals International Corporation (SPI), a wholly-owned subsidiary of Sumitomo Corporation.